Sandeep Singhal – Plasma Healthchek Diagnostics Pvt. Ltd.

• Sandeep Singhal founded Plasma HealthChek Diagnostics Pvt. Ltd. in October 2002, establishing a key player in the healthcare diagnostics sector.
• As the CEO, Sandeep led the company in developing innovative diagnostic solutions, focusing on improving health outcomes through advanced plasma-based technologies.
• Under Sandeep's leadership, Plasma HealthChek Diagnostics gained recognition for its commitment to quality and integrity in the diagnostics field, contributing to enhanced patient care.
• Sandeep co-founded Lotus Diabetes Pvt Ltd in March 2012, demonstrating a proactive approach to addressing diabetes management through innovative solutions.
• During the tenure at Lotus Diabetes, Sandeep's contributions were pivotal in fostering partnerships aimed at advancing diabetes care and education.
• Sandeep faced challenges common to startups, including navigating regulatory environments and establishing market presence, yet succeeded in growing the companies.
• Both organizations became known for their dedication to research and development, resulting in the launch of impactful products that addressed critical health needs.
• With an ongoing commitment to innovation, Sandeep continues to drive advancements that positively affect the healthcare landscape.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Plasma Healthchek Diagnostics Pvt. Ltd. corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Sandeep Singhal's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Plasma Healthchek Diagnostics Pvt. Ltd.'s official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)